Concepedia

Alessandra Brancalion

AB

4

Publications

299

Citations

4

H-Index

2012

Active since

Affiliations

Veneto Institute of Molecular Medicine(Current)

University of Padua

Alessandra Brancalion is an author at Veneto Institute of Molecular Medicine specializing in cell development, tumor biology, and cell signaling.

Top concepts

Publications per year

2012–2016

4

Publications

4

Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells

Sabrina Manni, Alessandra Brancalion, Elisa Mandato et al. · PLoS ONE · 2013 · 91 citations · Full text

, , +18

Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress–Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response

Sabrina Manni, Alessandra Brancalion, Laura Quotti Tubi et al. · Clinical Cancer Research · 2012 · 81 citations · Full text

Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia

Laura Quotti Tubi, Sara Canovas Nunes, Alessandra Brancalion et al. · Leukemia · 2016 · 70 citations

, , +13

Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity

Laura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion et al. · Journal of Hematology & Oncology · 2013 · 57 citations · Full text

Rows per page

1–4 of 4